A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans
PNAS Nexus · 29.09.2023 · 2 (10)
DOI: 10.1093/pnasnexus/pgad317 ↗Kurz gefasst
Fachartikel in der Zeitschrift PNAS Nexus, online erschienen am 09.10.2023. Verfasst von Vineeth Chandran Suja und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering and Applied Sciences, Harvard University, Boston, MA 02134, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Subcutaneous (subQ) injection is a common route for delivering biotherapeutics, wherein pharmacokinetics is largely influenced by drug transport in a complex subQ tissue microenvironment. The selection of good drug candidates with beneficial pharmacokinetics for subQ injections is currently limited by a lack of reliable testing models. To address this limitation, we report here a Subcutaneous Co-Culture Tissue-on-a-chip for Injection Simulation (SubCuTIS). SubCuTIS possesses a 3D coculture tissue architecture, and it allows facile quantitative determination of relevant scale independent drug transport rate constants. SubCuTIS captures key in vivo physiological characteristics of the subQ tissues, and it differentiates the transport behavior of various chemically distinct molecules. We supplemented the transport measurements with theoretical modeling, which identified subtle differences in the local absorption rate constants of seven clinically available mAbs. Accounting for first-order proteolytic catabolism, we established a mathematical framework to assess clinical bioavailability using the local absorption rate constants obtained from SubCuTIS. Taken together, the technology described here broadens the applicability of organs-on-chips as a standardized and easy-to-use device for quantitative analysis of subQ drug transport.
Autor:innen und Institutionen
- School of Engineering and Applied Sciences, Harvard University, Boston, MA 02134, USA.
- Wyss Institute for Biologically Inspired Engineering, 3 Blackfan Circle, Boston, MA 02115, USA.
- Sanofi, 350 Water St, Cambridge, MA 02141, USA.
- Sanofi R&D, Impasse Des Ateliers, Vitry-sur-Seine 94400 France.
Zitieren
APA
Chandran Suja, V., Qi, Q. M., Halloran, K., Zhang, J., Shaha, S., Prakash, S., Kumbhojkar, N., Deslandes, A., Huille, S., Gokarn, Y. R., & Mitragotri, S. (2023). A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans. PNAS Nexus, 2(10). https://doi.org/10.1093/pnasnexus/pgad317
Vancouver
Chandran Suja V, Qi QM, Halloran K, Zhang J, Shaha S, Prakash S, et al. A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans. PNAS Nexus. 2023;2(10). doi:10.1093/pnasnexus/pgad317
BibTeX
@article{ChandranSuja2023,
author = {Chandran Suja, Vineeth and Qi, Qin M and Halloran, Kevin and Zhang, Jifeng and Shaha, Suyog and Prakash, Supriya and Kumbhojkar, Ninad and Deslandes, Antoine and Huille, Sylvain and Gokarn, Yatin R and Mitragotri, Samir},
title = {A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans},
journal = {PNAS Nexus},
year = {2023},
volume = {2},
number = {10},
doi = {10.1093/pnasnexus/pgad317}
}
EUVIMED